Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

J Complement Med Res. 2020; 11(5): 41-48


Antimicrobial, anti-inflammatory and anticancer potential of Microbes mediated zinc oxide nanoparticles

S Rajeshkumar, Happy Agarwal, P Sivaperumal, Venkat Kumar Shanmugam, T Lakshmi.




Abstract

In current days, research on zinc oxide nanoparticles (ZnO NPs) have been added incredible consideration recognized to their distinctive properties. Remarkably, ZnO NPs exhibit the antimicrobial potential, further, it may be depends upon nanoparticle shape and size. Generally ZnO NPs synthesis by different physical and chemical methods and these process are more expensive as well is not environmentally eco-friendly. On the other hand, the microbial mediated ZnO NPs synthesis have been rapidly studied recently since microbial particles are cleaner, nor toxic, eco-friendly and biocompatible nature. Further, ZnO-NPs showed attractive antimicrobial effects due to enlarged particular surface area as the condensed particle size major to improved particle surface reactivity. Therefore, many researchers are interested in microbial ZnO-NPs and their bioactive potential studies. In this review, we have covered the microbial ZnO NPs synthesis and their antimicrobial, anti-inflammatory and anti-cancer prospective

Key words: metal oxide nanoparticles, biosynthesis, bacteria; Antimicrobial, Characterization






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.